Aidoc Medical Ltd., a startup with an artificial intelligence platform that helps doctors diagnose patients faster, has secured $150 million in funding.<\/p>\n
Goldman Sachs led the Series C round. Aidoc stated in its funding announcement today that Nvidia Corp.\u2019s NVentures startup investment arm, General Catalyst and SoftBank Investment Advisors chipped in as well. The software maker\u2019s total outside funding now exceeds $500 million.<\/p>\n
When doctors review a medical image such as an X-ray, they must not only diagnose the patient\u2019s condition but also determine how urgently care should be provided. Aidoc provides a platform called aiOS that speeds up the process. It also streamlines certain related tasks such as managing patient data.<\/p>\n
The software is powered by a custom foundation model called the Clinical AI Reasoning Engine, or CARE for short. According to Aidoc, clinical-grade AI models were historically trained to process a single type of medical data. CARE, in contrast, can analyze medical images, electronic health results, patient vitals and lab results.<\/p>\n
In January, the U.S. Food and Drug Administration cleared the model for diagnostic tasks across 11 disease indicators. Aidoc earlier secured regulatory approval for three other indicators.\u00a0<\/p>\n
The company says that CARE has a specificity of up to 99.7%, which corresponds to an under 1% chance of false positives. According to Aidoc, that\u2019s about an order of magnitude better than some competing models. The algorithm\u2019s mean specificity, a measure of diagnosis accuracy, is 98% across the 11 disease indicators that the FDA approved in January.<\/p>\n
Aidoc says CARE\u2019s accuracy enables its aiOS platform to spot incidentals. Those are potential disease indicators that doctors weren\u2019t necessarily expecting to find in a medical scan. After identifying an anomaly, aiOS prioritizes it based on its estimated severity. The software brings urgent issues to the attention of medical professionals via a mobile app.<\/p>\n
The platform also eases a number of other tasks. There\u2019s a spreadsheet-based data management interface that can be used to track the current status of patients. Furthermore, aiOS can automatically identify patients who may qualify to participate in clinical trials.<\/p>\n
Aidoc says its platform has been installed in nearly 2,000 hospitals worldwide. The medical teams at those facilities use it to process data about more than 60 million patients per year.<\/p>\n
The company will use its newly raised capital to expand international adoption of its aiOS platform. In addition, it plans to enhance the CARE model that underpins the software by equipping it with the ability to detect more disease indicators. It\u2019s also working on a feature that will automatically draft clinical reports based on data from medical images.<\/p>\n
Photo:\u00a0Pixabay<\/a><\/p>\n Support our mission to keep content open and free by engaging with theCUBE community. Join theCUBE\u2019s Alumni Trust Network, where technology leaders connect, share intelligence and create opportunities.<\/p>\n 15M+ viewers of theCUBE videos, powering conversations across AI, cloud, cybersecurity and more About SiliconANGLE Media<\/p>\n SiliconANGLE Media is a recognized leader in digital media innovation, uniting breakthrough technology, strategic insights and real-time audience engagement. As the parent company of SiliconANGLE<\/a>, theCUBE Network<\/a>, theCUBE Research<\/a>, CUBE365<\/a>, theCUBE AI<\/a> and theCUBE SuperStudios \u2014 with flagship locations in Silicon Valley and the New York Stock Exchange \u2014 SiliconANGLE Media operates at the intersection of media, technology and AI.<\/p>\n Founded by tech visionaries John Furrier and Dave Vellante, SiliconANGLE Media has built a dynamic ecosystem of industry-leading digital media brands that reach 15+ million elite tech professionals. Our new proprietary theCUBE AI Video Cloud is breaking ground in audience interaction, leveraging theCUBEai.com neural network to help technology companies make data-driven decisions and stay at the forefront of industry conversations.<\/p>\n","protected":false},"excerpt":{"rendered":"Aidoc Medical Ltd., a startup with an artificial intelligence platform that helps doctors diagnose patients faster, has secured…\n","protected":false},"author":2,"featured_media":22525,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2],"tags":[24,25,2934,15608,396],"class_list":{"0":"post-22524","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-ai","8":"tag-ai","9":"tag-artificial-intelligence","10":"tag-maria-deutscher","11":"tag-nvidias-nventures-backs-150m-round-for-medical-ai-startup-aidoc","12":"tag-siliconangle"},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/ai\/wp-json\/wp\/v2\/posts\/22524","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/ai\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/ai\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ai\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ai\/wp-json\/wp\/v2\/comments?post=22524"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/ai\/wp-json\/wp\/v2\/posts\/22524\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ai\/wp-json\/wp\/v2\/media\/22525"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/ai\/wp-json\/wp\/v2\/media?parent=22524"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/ai\/wp-json\/wp\/v2\/categories?post=22524"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/ai\/wp-json\/wp\/v2\/tags?post=22524"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
\n11.4k+ theCUBE alumni \u2014 Connect with more than 11,400 tech and business leaders shaping the future through a unique trusted-based network.<\/p>\n